CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Neuroscience Startups (947)
InVivo Therapeutics (NASDAQ: NVIV) develops and commercializes technologies for the treatment of spinal cord injuries (SCI).
Company (IPO / Went public)
Phone: 617-863-5500
One Kendall Square
Building 1400 East, Floor 4
Cambridge, 02139
Massachusetts, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of use | Sep 26, 2017 | Application | |
| Methods and systems for delivery of a trail of a therapeutic substance into an anatomical space | Nov 28, 2016 | Application | |
| Compositions and methods for preparing an injectable medium for administration into the central nervous system | Nov 28, 2016 | Application | |
| Thiol-ene functionalized hydrogels | Sep 08, 2015 | Application | |
| Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents | Nov 26, 2014 | Application |
